CalciMedica, Inc. (CALC)
NASDAQ: CALC · Real-Time Price · USD
0.670
+0.009 (1.36%)
Mar 6, 2026, 9:38 AM EST - Market open
CalciMedica Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 7.89 | 9.73 | 9.52 | 5.84 | 5.06 | |
| Research & Development | 15.23 | 14.48 | 12.36 | 8.35 | 16.48 | |
| Operating Expenses | 23.12 | 24.2 | 21.88 | 14.19 | 21.54 | |
| Operating Income | -23.12 | -24.2 | -21.88 | -14.19 | -21.54 | |
| Interest Expense | -1.42 | - | - | -0.13 | - | |
| Interest & Investment Income | 0.71 | 1.01 | - | - | - | |
| Other Non Operating Income (Expenses) | -5.73 | 9.49 | 3.72 | 3.76 | -1.96 | |
| EBT Excluding Unusual Items | -29.56 | -13.7 | -18.16 | -10.57 | -23.5 | |
| Merger & Restructuring Charges | - | - | -16.2 | - | - | |
| Other Unusual Items | - | - | - | 2.75 | - | |
| Pretax Income | -29.56 | -13.7 | -34.36 | -7.82 | -23.5 | |
| Net Income | -29.56 | -13.7 | -34.36 | -7.82 | -23.5 | |
| Preferred Dividends & Other Adjustments | - | - | - | 1.32 | - | |
| Net Income to Common | -29.56 | -13.7 | -34.36 | -9.14 | -23.5 | |
| Shares Outstanding (Basic) | 15 | 11 | 4 | 0 | 3 | |
| Shares Outstanding (Diluted) | 15 | 11 | 4 | 0 | 3 | |
| Shares Change (YoY) | 33.48% | 150.68% | 5354.75% | -96.97% | 3.08% | |
| EPS (Basic) | -1.97 | -1.22 | -7.66 | -111.16 | -8.65 | |
| EPS (Diluted) | -1.97 | -1.22 | -7.66 | -111.16 | -8.65 | |
| Free Cash Flow | -21.21 | -21.15 | -25.81 | -11.76 | -20.72 | |
| Free Cash Flow Per Share | -1.41 | -1.88 | -5.75 | -143.00 | -7.63 | |
| EBITDA | -23.08 | -24.15 | -21.82 | -14.14 | -21.5 | |
| D&A For EBITDA | 0.05 | 0.06 | 0.06 | 0.05 | 0.04 | |
| EBIT | -23.12 | -24.2 | -21.88 | -14.19 | -21.54 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.